Karen A. Cashmere
Chief Commercial OfficerMs. Karen A. Cashmere has been the Chief Commercial Officer of ZyVersa Therapeutics, Inc. since December 12, 2022 and served in the same capacity at Old ZyVersa from January 2019 to December 2022, and as Acting Vice President, Development and Marketing from August 2014 to January 2019. Ms. Cashmere has more experience in business planning and execution for biopharmaceutical and medical device companies ranging in size from start-up to Fortune 100 companies. She formerly led the Marketing Communications function at Mako Surgical Corporation Ms. Cashmere served as Acting Vice President of Development and Marketing of Variant Pharmaceuticals, Inc. She served as Vice President of Marketing at RECRO Pharma, Inc. Ms. Cashmere served as Senior Vice President of New Product Marketing of Auxilium Pharmaceuticals Inc. since May 2006. She was responsible for pipeline planning and pre-launch/launch strategic planning and implementation for Xiaflex®, a biologic with numerous potential orphan indications, including Dupuytren's contracture and Peyronie's disease. Ms. Cashmere joined Auxilium in September 2005 as a full time consultant to start up the New Product Marketing Department and to begin assessing market potential and developing marketing strategies for Auxilium's robust new product pipeline. Since May 2006, Ms. Cashmere served as Senior Vice President of New Product Marketing of Auxilium. She has over 20 years of pharmaceutical business experience. Ms. Cashmere has proven track record for directing development and implementation of launch strategies for new products in diverse markets. Ms. Cashmere led Auxilium’s strategic partnership review process, resulting in out-licensing European rights of a key asset with multiple indications, Xiaflex, to Pfizer. Prior to Auxilium, Ms. Cashmere was Sr. Director, Marketing at Andrx Laboratories, responsible for a newly created business unit focusing on commercialization of pipeline products for men’s health. Earlier she held strategic marketing positions at Noven, Serono, and Abbott. Prior to joining Auxilium, Ms. Cashmere served positions of increasing responsibility at Abbott Nutritional and Pharmaceutical Divisions, Serono, Novogyne (Noven/Novartis Joint Venture), and Andrx Branded Division where she started up a Urology Division. She completed an Executive Leadership Program while at Abbott. Ms. Cashmere holds BS and M.S. degrees in Nutrition/Biochemistry from The Ohio State University.
Positions
- Company NameZyVersa Therapeutics, Inc.Stock CodeZVSAPositionChief Commercial Officer
